Trials / Completed
CompletedNCT00255775
Broccoli Sprout Extract in Preventing Lung Cancer in Smokers
Evaluation of the Biological Effects of Broccoli Sprout Extract in Smokers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Chemoprevention is the use of certain drugs or substances to keep cancer from forming, growing, or coming back. The use of broccoli sprout extract may prevent lung cancer. PURPOSE: This clinical trial is studying how well broccoli sprout extract works in preventing lung cancer in smokers.
Detailed description
OBJECTIVES: Primary * Evaluate the effect of broccoli sprout extract on levels of DNA adducts in participants who smoke. * Determine the effectiveness of broccoli sprout extract in reducing tobacco-carcinogen induced DNA adducts in these participants. Secondary * Determine the effects of broccoli sprout extract on markers of the Nrf2 pathway in these participants. * Determine the effectiveness of broccoli sprout extract, in increasing the activity of the Nrf2 pathway, in these participants. * Evaluate the feasibility of using lymphocytes and buccal cells to monitor DNA adducts and changes in the Nrf2 pathway in these participants. OUTLINE: Participants are stratified according to GST genotypic polymorphism (M1 vs T1). Participants receive oral broccoli sprout extract daily for 3 weeks. Participants keep a daily diary of their eating and smoking habits for 3 weeks before, during, and for 3 weeks after study treatment. They must continue to smoke during the study, but are encouraged to quit after completing the study treatment. PROJECTED ACCRUAL: A total of 70 participants will be accrued for this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | broccoli sprout extract | |
| PROCEDURE | complementary or alternative medicine procedure |
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2009-05-01
- First posted
- 2005-11-21
- Last updated
- 2010-08-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00255775. Inclusion in this directory is not an endorsement.